Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Dobson

Showing results (481-490 of 516) with videos related to

Pageof 52
Sort By:
Science Advances|March 3, 2016
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's diseaseJohnny Habchi, Paolo Arosio, Michele Perni, et al.
International Journal of Molecular Sciences|July 8, 2020
Rationally Designed Antibodies as Research Tools to Study the Structure-Toxicity Relationship of Amyloid-β OligomersRyan Limbocker, Benedetta Mannini, Rodrigo Cataldi, et al.
ACS Nano|December 19, 2015
Microfluidic Diffusion Analysis of the Sizes and Interactions of Proteins under Native Solution ConditionsPaolo Arosio, Thomas Müller, Luke Rajah, et al.
Journal of Molecular Biology|July 13, 2010
Structure and properties of a complex of α-synuclein and a single-domain camelid antibodyErwin J De Genst, Tim Guilliams, Joke Wellens, et al.
Nature Structural & Molecular Biology|March 2, 2016
A structural ensemble of a ribosome-nascent chain complex during cotranslational protein foldingLisa D Cabrita, AnaÏs M E Cassaignau, Helene M M Launay, et al.
Antioxidants & Redox Signaling|November 14, 2015
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's DiseaseEmma Deas, Nunilo Cremades, Plamena R Angelova, et al.
Chemical Society Reviews|July 8, 2020
Half a century of amyloids: past, present and futurePu Chun Ke, Ruhong Zhou, Louise C Serpell, et al.
Cell|May 29, 2012
Direct observation of the interconversion of normal and toxic forms of α-synucleinNunilo Cremades, Samuel I A Cohen, Emma Deas, et al.
Journal of the American Chemical Society|February 18, 2014
The role of stable α-synuclein oligomers in the molecular events underlying amyloid formationNikolai Lorenzen, Søren Bang Nielsen, Alexander K Buell, et al.
Biochemistry|September 26, 2008
Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrilsPak-Ho Chan, Els Pardon, Linda Menzer, et al.
Pageof 52

Showing results (481-490 of 516) with videos related to

Sort By:
Pageof 52
Science Advances|March 3, 2016
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's diseaseJohnny Habchi, Paolo Arosio, Michele Perni, et al.
International Journal of Molecular Sciences|July 8, 2020
Rationally Designed Antibodies as Research Tools to Study the Structure-Toxicity Relationship of Amyloid-β OligomersRyan Limbocker, Benedetta Mannini, Rodrigo Cataldi, et al.
ACS Nano|December 19, 2015
Microfluidic Diffusion Analysis of the Sizes and Interactions of Proteins under Native Solution ConditionsPaolo Arosio, Thomas Müller, Luke Rajah, et al.
Journal of Molecular Biology|July 13, 2010
Structure and properties of a complex of α-synuclein and a single-domain camelid antibodyErwin J De Genst, Tim Guilliams, Joke Wellens, et al.
Nature Structural & Molecular Biology|March 2, 2016
A structural ensemble of a ribosome-nascent chain complex during cotranslational protein foldingLisa D Cabrita, AnaÏs M E Cassaignau, Helene M M Launay, et al.
Antioxidants & Redox Signaling|November 14, 2015
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's DiseaseEmma Deas, Nunilo Cremades, Plamena R Angelova, et al.
Chemical Society Reviews|July 8, 2020
Half a century of amyloids: past, present and futurePu Chun Ke, Ruhong Zhou, Louise C Serpell, et al.
Cell|May 29, 2012
Direct observation of the interconversion of normal and toxic forms of α-synucleinNunilo Cremades, Samuel I A Cohen, Emma Deas, et al.
Journal of the American Chemical Society|February 18, 2014
The role of stable α-synuclein oligomers in the molecular events underlying amyloid formationNikolai Lorenzen, Søren Bang Nielsen, Alexander K Buell, et al.
Biochemistry|September 26, 2008
Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrilsPak-Ho Chan, Els Pardon, Linda Menzer, et al.
Pageof 52